PH-0273 Chemoradiotherapy for NSCLC patients with a high predicted risk of irradical resection. (August 2021) - van Joolingen, H.; Rasing, M.; Peters, M.; van Lindert, A.; de Heer, L.; Aarts, M.; Verhoeff, J.; van Rossum, P.